Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-s
about
Molecular mechanism of monoamine oxidase A gene regulation under inflammation and ischemia-like conditions: key roles of the transcription factors GATA2, Sp1 and TBPRole of PXR in Hepatic Cancer: Its Influences on Liver Detoxification Capacity and Cancer ProgressionBile formation and secretion.Role of multidrug resistance-associated protein 4 in the basolateral efflux of hepatically derived enalaprilat.Quantitative assessment of the multiple processes responsible for bilirubin homeostasis in health and disease.Swertianlarin, isolated from Swertia mussotii Franch, increases detoxification enzymes and efflux transporters expression in rats.Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats.Toward predicting drug-induced liver injury: parallel computational approaches to identify multidrug resistance protein 4 and bile salt export pump inhibitors.Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstructionInterleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells.Fibrates and cholestasisSwertianlarin, an Herbal Agent Derived from Swertia mussotii Franch, Attenuates Liver Injury, Inflammation, and Cholestasis in Common Bile Duct-Ligated RatsLiver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXRCanalicular membrane MRP2/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasisDrug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.Enhanced membrane-tethered mucin 3 (MUC3) expression by a tetrameric branched peptide with a conserved TFLK motif inhibits bacteria adherence.Nuclear receptors as drug targets in cholestatic liver diseases.Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death.Prevention of gallstones by Lidan Granule: Insight into underlying mechanisms using a guinea pig modelA perspective on efflux transport proteins in the liverHepatic basolateral efflux contributes significantly to rosuvastatin disposition I: characterization of basolateral versus biliary clearance using a novel protocol in sandwich-cultured hepatocytesRisk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.Loss of von Hippel-Lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2α and regulation of bile acid homeostasis.Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.Mitochondria-meditated pathways of organ failure upon inflammation.Effect of Liver Disease on Hepatic Transporter Expression and Function.Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?Activation of p38 Mitogen-Activated Protein Kinase by Clotrimazole Induces Multidrug Resistance-Associated Protein 3 Activation through a Novel Transcriptional Element.Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms.Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment.The molecular mechanism underlying the induction of hepatic MRP3 expression and function by omeprazole.
P2860
Q28259446-997E97CE-2249-4917-9B6F-322B24AC2950Q28552770-5F0CAA88-0B50-488B-AA48-1AE9E9189B8DQ33881922-3744AB5D-F192-46BA-A710-12985C87F5CFQ34125053-90F6C742-5CAC-48DE-9C54-7DFCD595B84CQ34155271-A0949C20-7EDC-4A28-81AA-0F7483684D7FQ35145151-48AE9165-C1C1-4922-87DC-1F4DCB63225BQ35479252-7378CE55-4049-40B8-B407-F925F05322B7Q35531766-2E7024AF-DD09-4490-8CF4-340F124AAC67Q35583781-866FEFD9-9CE2-4F92-B177-437E6986F789Q35751457-A8A56AEF-5998-43E6-A2FA-9D45446C0A58Q35889448-3F81792A-188E-4319-AC5D-A9ED97CFB402Q35932294-360FD0A1-7CD0-4075-8BF4-00121972E131Q36173223-954DB40B-B085-479A-99E1-C247578E38C7Q36390520-9205DFB7-5F0A-4361-89A4-C21C35AAAE2AQ36391044-91E02D1E-5D1E-4905-9490-11B283C56815Q36635893-AE5CDC9D-02D5-4121-B92F-248A78C5ECAFQ36786270-C68F7CD0-9C33-4CA9-83A1-12D9E977337DQ36795583-20E4F3DE-331D-4436-9360-7658053F9A84Q37001741-9BDD7EE5-695B-4AA0-AC3A-F1243032751AQ37050337-57681F09-8271-4AD4-8A97-0CA73D245B3AQ37331801-5E67BFBE-8F87-4747-932F-5D4DF65F6FD8Q37663395-FE3BCB43-E6E9-47D9-B2DD-D2F09CF4110BQ37713582-5D0D4465-43DF-422F-9199-68663FE93064Q38183877-F7BE66E2-B625-4BB0-9122-3712053C7EC9Q38746466-54C08455-999A-4EDC-AFFA-BABF2D398164Q38808182-F5975923-DFFF-4A1E-91B9-8EC04255AC60Q40386706-B98C10CC-7B14-4AD0-8FFA-00D5C73C4717Q42497435-85345444-40F2-4B98-8CB7-6E25691A347FQ52682525-0A2BF506-E3AE-40B6-84B6-A148DCB13399Q53127205-6E699EC1-0E0F-4206-BF4E-6F458578D049Q53635376-F45D2D7B-08DD-4192-AA35-7609E30BBDB9
P2860
Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-s
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Elevated hepatic multidrug res ...... ess-activated protein kinase-s
@ast
Elevated hepatic multidrug res ...... ess-activated protein kinase-s
@en
type
label
Elevated hepatic multidrug res ...... ess-activated protein kinase-s
@ast
Elevated hepatic multidrug res ...... ess-activated protein kinase-s
@en
prefLabel
Elevated hepatic multidrug res ...... ess-activated protein kinase-s
@ast
Elevated hepatic multidrug res ...... ess-activated protein kinase-s
@en
P2093
P2860
P356
P1433
P1476
Elevated hepatic multidrug res ...... ess-activated protein kinase-s
@en
P2093
Huaizhi Wang
James L Boyer
Rongquan Wang
Shi-Ying Cai
Tianli Xiao
Wensheng Chen
Xiaochong He
P2860
P304
P356
10.1002/HEP.24801
P407
P577
2012-05-01T00:00:00Z